GW0742: What It Is, Research and WADA Status | Dose Track
App Library Tools Pricing Download
[Research compound · Compound guide]

GW0742: what it is, research and status

Amounts studied · Approval status · Half-life notes

What is GW0742?

GW0742 is a synthetic drug that switches on PPAR-delta, a receptor involved in how the body handles fat. GlaxoSmithKline made it in the same research program as cardarine (GW501516); it has been studied in cells and animals, and it is not approved for people.

Also known as: GW610742, GW-0742.

Amounts studied

For GW0742, there is no approved product and no published human trial, so there are no label strengths or studied human amounts.

Approval status and how it is used

GW0742 is not approved anywhere we could find, and we found no product in FDA's Drugs@FDA database. GSK chemists described it in 2003, alongside GW501516, as a selective PPAR-delta activator (Sznaidman 2003).

WADA bans PPAR-delta agonists as a class under "metabolic modulators" (S4.4.1), in and out of competition; its 2026 list names GW1516 (cardarine) as an example. For what is known about the risks of this drug class, see the cardarine page.

We found no published human trial of GW0742 that we could cite.

GW0742 half-life and time to peak

  • Half-lifeNot listed
  • Time to peak (Tmax)Not listed

We could not find a published human half-life or time to peak, so we do not list one. Figures quoted online usually come from animal studies or computer models.

How to track GW0742 in Dose Track

  1. Add GW0742 as a custom compound. Start typing its name and Dose Track fills in the details from its research library for you to check, and it sits next to everything else you take.
  2. Log each dose when you take it so your history shows exactly what you took and when.
  3. Set reminders on your own schedule, whether that is daily, weekly or every few days.
  4. Your log is stored on your phone and no account is needed. Data only leaves it for features you choose, like AI answers and lab reading.

How Dose Track handles peptides · Reconstitution calculator · Half-life calculator

Cardarine (GW501516)GW501516, GW1516 SR9009 (Stenabolic)Stenabolic, SR-9009 SLU-PP-332 MOTS-c

Frequently asked questions

What is the half-life of GW0742?+
We could not find a published human half-life or time to peak, so we do not list one. Figures quoted online usually come from animal studies or computer models.
Is GW0742 the same as cardarine?+
No, but they are close relatives. Both were made by GSK as PPAR-delta activators and were described in the same 2003 paper (Sznaidman 2003). WADA bans the whole class.
Can I track GW0742 in Dose Track?+
Yes. GW0742 is in Dose Track's research library, so when you add it as a custom compound its details are filled in for you to check. You can then log each dose next to your other compounds, set reminders on your own schedule, and see your history next to your lab results. Your log is stored on your phone and no account is needed. Data only leaves it for features you choose, like AI answers and lab reading.

Sources

  1. Sznaidman ML, et al. Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta): synthesis and biological activity. Bioorg Med Chem Lett. 2003;13(9):1517-1521.
  2. World Anti-Doping Agency. 2026 Prohibited List (S0 non-approved substances; S1 anabolic agents; S4.1 aromatase inhibitors; S4.4.1 metabolic modulators).

All compound guides · Reconstitution calculator · Supported medications